Patent directory · USPTO A61K / A61P
Patents matching “ONC”
274 pharma patents match "ONC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 274 pharmaceutical patents matching "ONC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 20260060930
New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases
granted -
WO 2026013643
PROCÉDÉS ET COMPOSITIONS POUR CONCEVOIR DES CHAÎNES D'ÉPITOPES AVEC DES LIEURS
granted -
WO 2026010917
FORMULATIONS NUTRITIONNELLES PERMETTANT DE MAINTENIR DES MICROBIOTE ET FONCTION INTESTINAUX SAINS
granted -
WO 2025237912
INHIBITEURS DE KEAP1 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE LA BRONCHECTASIE
granted -
US 12427212
Nectin-4 binding miniproteins, conjugates and uses thereof
granted -
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12404497
Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof
granted -
US 12377115
Combination immunotherapies for treatment of cancer
granted -
US 12370229
Methods of treating bladder cancer
granted -
US 12358976
Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
granted -
WO 2025137347
FORMULATIONS DE RISANKIZUMAB À HAUTE CONCENTRATION
granted -
US 12331079
Oncolytic virus platform to treat cancers with myxoma virus
granted -
US 12263173
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12194064
Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids
granted -
US 12162877
Human dihydroorotate dehydrogenase (hDHODH) inhibitors and their use in targeting oncological diseases sensitive to pyrimidine starvation
granted -
US 12144813
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12122837
Oncostatin M receptor antigen binding proteins
granted -
US 12097210
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 12090183
Methods of treating solid or lymphatic tumors by combination therapy
granted -
US 12059443
Method for treating cancer using dengue virus serotype 1 (DENV-1)
granted -
US 12036280
High concentration protein formulation
granted -
US 12018011
Macrocyclic compounds and compositions, and methods of preparing and using the same
granted -
US 12005194
Configurable oxygen concentrator and related method
granted -
US 11975106
Uses of halogenated xanthenes in oncology and virology
granted